A Randomized, Multiple Dose, Double Blind, 5-Way Crossover Study of the Electrocardiographic (ECG) Effects of Bilastine

This study has been completed.

Study NCT00419783 Information provided by Faes Farma, S.A.

First Received: January 8, 2007 Last Updated: January 9, 2009 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	December 2006
Primary Completion Date:	December 2006 (Final data collection date for primary outcome measure)